These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38662902)

  • 1. An update on migraine: Current and new treatment options.
    Hervias T
    JAAPA; 2024 May; 37(5):1-7. PubMed ID: 38662902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.
    Ailani J; Burch RC; Robbins MS;
    Headache; 2021 Jul; 61(7):1021-1039. PubMed ID: 34160823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
    VanderPluym JH; Halker Singh RB; Urtecho M; Morrow AS; Nayfeh T; Torres Roldan VD; Farah MH; Hasan B; Saadi S; Shah S; Abd-Rabu R; Daraz L; Prokop LJ; Murad MH; Wang Z
    JAMA; 2021 Jun; 325(23):2357-2369. PubMed ID: 34128998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Neuromodulation in Migraine.
    Blech B; Starling AJ
    Curr Pain Headache Rep; 2020 Dec; 24(12):78. PubMed ID: 33326063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Medications for the Treatment of Migraine.
    Ceriani CEJ; Wilhour DA; Silberstein SD
    Headache; 2019 Oct; 59(9):1597-1608. PubMed ID: 31559638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive Migraine Treatment.
    Burch R
    Continuum (Minneap Minn); 2021 Jun; 27(3):613-632. PubMed ID: 34048395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's New in the Treatment of Migraine?
    Digre KB
    J Neuroophthalmol; 2019 Sep; 39(3):352-359. PubMed ID: 31393282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Treatments in Episodic Migraine.
    Grimsrud KW; Halker Singh RB
    Curr Pain Headache Rep; 2018 Jul; 22(9):61. PubMed ID: 30014208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on noninvasive neuromodulation for migraine treatment-Vagus nerve stimulation.
    Schoenen J; Ambrosini A
    Prog Brain Res; 2020; 255():249-274. PubMed ID: 33008508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Migraine.
    Holdridge A; Buczyner J; Aymat CC; Le A
    Semin Neurol; 2022 Oct; 42(5):558-570. PubMed ID: 36513096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A device review of Relivion®: an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder.
    Daniel O; Sharon R; Tepper SJ
    Expert Rev Med Devices; 2021 Apr; 18(4):333-342. PubMed ID: 33787443
    [No Abstract]   [Full Text] [Related]  

  • 12. External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial.
    Daniel O; Tepper SJ; Deutsch L; Sharon R
    Pain Ther; 2022 Sep; 11(3):907-922. PubMed ID: 35661128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study.
    Kinfe TM; Pintea B; Muhammad S; Zaremba S; Roeske S; Simon BJ; Vatter H
    J Headache Pain; 2015; 16():101. PubMed ID: 26631234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel migraine treatment with CGRP-related monoclonal antibodies].
    Shibata M
    Rinsho Shinkeigaku; 2020 Oct; 60(10):668-676. PubMed ID: 32893246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive Treatment for Episodic Migraine.
    Parikh SK; Silberstein SD
    Neurol Clin; 2019 Nov; 37(4):753-770. PubMed ID: 31563231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse.
    van Hoogstraten WS; MaassenVanDenBrink A
    J Headache Pain; 2019 May; 20(1):54. PubMed ID: 31096904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants.
    Do TP; Al-Saoudi A; Ashina M
    Rev Neurol (Paris); 2021 Sep; 177(7):827-833. PubMed ID: 34294458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update.
    Charles AC; Digre KB; Goadsby PJ; Robbins MS; Hershey A;
    Headache; 2024 Apr; 64(4):333-341. PubMed ID: 38466028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging target-based paradigms to prevent and treat migraine.
    Silberstein SD
    Clin Pharmacol Ther; 2013 Jan; 93(1):78-85. PubMed ID: 23212108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications Approved for Preventing Migraine Headaches.
    Spindler BL; Ryan M
    Am J Med; 2020 Jun; 133(6):664-667. PubMed ID: 32145209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.